Intelligent Bio Solutions Inc.
INBS
$2.36
$0.010.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.91M | 3.58M | 3.29M | 3.05M | 2.94M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.91M | 3.58M | 3.29M | 3.05M | 2.94M |
| Cost of Revenue | 2.06M | 1.93M | 1.87M | 1.81M | 1.21M |
| Gross Profit | 1.85M | 1.66M | 1.42M | 1.25M | 1.73M |
| SG&A Expenses | 10.17M | 10.13M | 9.60M | 8.89M | 8.84M |
| Depreciation & Amortization | 1.18M | 1.19M | 1.21M | 1.21M | 1.19M |
| Other Operating Expenses | -815.60K | -823.20K | -884.10K | -816.90K | -510.90K |
| Total Operating Expenses | 15.08M | 14.37M | 13.74M | 13.48M | 13.30M |
| Operating Income | -11.17M | -10.79M | -10.44M | -10.43M | -10.36M |
| Income Before Tax | -11.65M | -11.33M | -10.91M | -10.60M | -10.30M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.65 | -11.33 | -10.91 | -10.60 | -10.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 40.40K | 40.60K | 38.90K | 36.10K | 34.70K |
| Net Income | -11.61M | -11.29M | -10.87M | -10.57M | -10.26M |
| EBIT | -11.17M | -10.79M | -10.44M | -10.43M | -10.36M |
| EBITDA | -10.21M | -9.84M | -9.46M | -9.46M | -9.41M |
| EPS Basic | -12.52 | -15.13 | -17.27 | -20.83 | -25.57 |
| Normalized Basic EPS | -7.40 | -9.03 | -10.38 | -12.79 | -15.95 |
| EPS Diluted | -12.52 | -15.13 | -17.27 | -20.83 | -25.59 |
| Normalized Diluted EPS | -7.40 | -9.03 | -10.38 | -12.79 | -15.95 |
| Average Basic Shares Outstanding | 4.10M | 3.08M | 2.59M | 2.11M | 1.72M |
| Average Diluted Shares Outstanding | 4.10M | 3.08M | 2.59M | 2.11M | 1.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |